Yao M, Keogh A, Spratt P, dos Remedios C G, Kiessling P C
Department of Anatomy and Histology, University of Sydney, New South Wales, Australia.
J Mol Cell Cardiol. 1996 Jan;28(1):95-101. doi: 10.1006/jmcc.1996.0009.
This is the first report to determine deoxyribonuclease I (DNase I) levels in the human myocardium and the first to demonstrate an increased DNase I level associated with end-stage heart failure due to idiopathic dilated cardiomyopathy (IDCM) compared to non-diseased heart samples. Left ventricular samples were obtained following transplantation from failing hearts of 13 patients diagnosed with IDCM and from four unused donor hearts. Using a zymogram technique, we show that the DNase I levels of the IDCM heart samples were significantly elevated (range 0.65-2.75 pg DNase I/microgram protein, mean +/- S.E. of 1.69 +/- 0.22 pg/micrograms) compared to four non-diseased, donor heart samples (range 0.12-0.35 pg/microgram protein, mean +/- S.E. of 0.22 +/- 0.05 pg/microgram). The DNase I extracted from heart tissue was characterized by: (1) a co-migration with bovine pancreatic DNase I; (2) a pH dependence consistent with DNase I; (3) a dependence of its activity on both Ca2+ and Mg2+ and an inhibition by Zn2+; and (4) an inhibition of its activity in the presence of monomeric rabbit skeletal muscle actin. The elevated DNase I levels associated with heart failure due to IDCM suggests that apoptosis may be implicated in pathophysiology of this disorder.
这是首篇测定人心肌中脱氧核糖核酸酶I(DNase I)水平的报告,也是首篇证明与特发性扩张型心肌病(IDCM)所致终末期心力衰竭相关的DNase I水平相较于未患病心脏样本有所升高的报告。左心室样本取自13例被诊断为IDCM的衰竭心脏移植后的心脏以及4个未使用的供体心脏。运用酶谱技术,我们发现与4个未患病的供体心脏样本(范围为0.12 - 0.35 pg/微克蛋白质,平均值±标准误为0.22±0.05 pg/微克)相比,IDCM心脏样本的DNase I水平显著升高(范围为0.65 - 2.75 pg DNase I/微克蛋白质,平均值±标准误为1.69±0.22 pg/微克)。从心脏组织中提取的DNase I具有以下特征:(1)与牛胰腺DNase I共迁移;(2)pH依赖性与DNase I一致;(3)其活性依赖于Ca2+和Mg2+,并受Zn2+抑制;(4)在单体兔骨骼肌肌动蛋白存在时其活性受到抑制。与IDCM所致心力衰竭相关的DNase I水平升高表明,细胞凋亡可能参与了这种疾病的病理生理过程。